Bahrain authorizes use of Chinese Sinopharm’s COVID-19 vaccine
DUBAI: National Health Regulatory Authority (NHRA) of Bahrain Sunday approved the use of China-based Sinopharm’s COVID-19 vaccine in the country. The approval follows the success of Sinopharm’s clinical trials across several countries, where Phase III results showed an 86 percent…